Table 1.
Variable | Mean/N/Median | SD/%/IQR |
---|---|---|
Demographic | ||
Age (years-old; median, IQR) | 72.00 | 15.00 |
Male (N, %) | 63 | 66.32 |
BMI (kg/m2; median, IQR) | 19.60 | 2.37 |
Smoking status (N, %) | ||
Smoker | 69 | 72.63 |
Ex-smoker | 12 | 12.63 |
Clinical | ||
Course of disease (years; median, IQR) | 10.00 | 5.00 |
Frequency of acute exacerbation in the past 1 year (median, IQR) | 1.00 | 1.00 |
Exacerbation frequency ≥ 2 | 35 | 36.84 |
CAT score (median, IQR) | 18.00 | 7.00 |
mMRC score (median, IQR) | 2.00 | 1.00 |
Lung Function | ||
FEV1 (L; median, IQR) | 1.20 | 0.60 |
FEV1%pred (median, IQR) | 57.21 | 16.28 |
FEV1/FVC% (mean, SD) | 53.94 | 7.85 |
Hematological Indicators | ||
WBC (×109; mean, SD) | 8.26 | 1.97 |
NE (×109; median, IQR) | 5.63 | 2.28 |
EO (×109; median, IQR) | 0.10 | 0.41 |
hs-CRP (mg/L; median, IQR) | 5.50 | 6.64 |
IL-6 (pg/mL; median, IQR) | 8.80 | 26.07 |
Notes: Normal range of WBC, NE, EO, hs-CRP and IL-6 (3.5~9.5×109, 1.8~6.3×109, 0.02~0.52×109, 0~5 mg/L, 0~7 pg/mL).
Abbreviations: IQR, interquartile range (25th–75th percentile); N, number; SD, standard deviation; BMI, body mass index; CAT, chronic obstructive pulmonary disease assessment test; mMRC, modified British medical research council; FEV1, forced expiratory volume in 1 second; FEV1%pred, FEV1 as a percentage of the predicted value; FVC, forced vital capacity; WBC, white blood cell count; NE, absolute neutrophil count; EO, absolute eosinophil count; hs-CRP, hypersensitive C reactive protein; IL-6, interleukin-6.